Jay Venkatesan - Nov 7, 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Jay R. Venkatesan
Stock symbol
SER
Transactions as of
Nov 7, 2025
Transactions value $
$0
Form type
4
Date filed
11/10/2025, 07:57 PM
Previous filing
May 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Venkatesan Jay Director 601 GENOME WAY, SUITE 2001, HUNTSVILLE /s/ Jay R. Venkatesan 2025-11-10 0001413350

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +10K $0.00 10K Nov 7, 2025 Common Stock 10K $3.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.